- Home
- ADAP vs PVBC Comparison
ADAP vs PVBC Comparison
Compare ADAP & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- PVBC
- Stock Information
- Founded
- ADAP 2008
- PVBC 1913
- Country
- ADAP United Kingdom
- PVBC United States
- Employees
- ADAP N/A
- PVBC N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- ADAP Health Care
- PVBC Finance
- Exchange
- ADAP Nasdaq
- PVBC Nasdaq
- Market Cap
- ADAP 212.3M
- PVBC 184.9M
- IPO Year
- ADAP 2015
- PVBC 2015
- Fundamental
- Price
- ADAP $0.62
- PVBC $11.79
- Analyst Decision
- ADAP Strong Buy
- PVBC Hold
- Analyst Count
- ADAP 4
- PVBC 1
- Target Price
- ADAP $2.79
- PVBC $12.00
- AVG Volume (30 Days)
- ADAP 2.3M
- PVBC 30.4K
- Earning Date
- ADAP 11-13-2024
- PVBC 01-23-2025
- Dividend Yield
- ADAP N/A
- PVBC N/A
- EPS Growth
- ADAP N/A
- PVBC N/A
- EPS
- ADAP N/A
- PVBC 0.32
- Revenue
- ADAP $175,041,000.00
- PVBC $55,219,000.00
- Revenue This Year
- ADAP $204.91
- PVBC N/A
- Revenue Next Year
- ADAP N/A
- PVBC $5.01
- P/E Ratio
- ADAP N/A
- PVBC $37.32
- Revenue Growth
- ADAP 146.27
- PVBC N/A
- 52 Week Low
- ADAP $0.43
- PVBC $7.36
- 52 Week High
- ADAP $2.05
- PVBC $12.32
- Technical
- Relative Strength Index (RSI)
- ADAP 37.29
- PVBC 61.12
- Support Level
- ADAP $0.57
- PVBC $11.31
- Resistance Level
- ADAP $0.61
- PVBC $11.99
- Average True Range (ATR)
- ADAP 0.04
- PVBC 0.28
- MACD
- ADAP -0.00
- PVBC -0.00
- Stochastic Oscillator
- ADAP 27.46
- PVBC 77.94
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.